This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

IMU - Imugene Limited

Jump to new
Is that the reason why the price has jumped 7% on the 27/11/2023?

Has everyone got their bonuses at the same time, and all decided to put it into IMU? Have they all waited for this day in particular to buy a position?

I was more so asking what has happened today that has caused a rise...

When looking at a 7% rise with no immediate recent announcements. Do you just go back and assume that it is from the announcement from the start of the month?

BTW its a 10% rise now...
 
Country Lad said:
It is a good idea to look at the point a sharp rise starts and look for announcements around that time - like this one. You mentioned Morningstar report - have you read it? does it give clues?
Click to expand...
I think you've caught me out here...

No i haven't read it, but from now on if i see a report with a recommendation i will read it.

M
 

Iggy picked it in the monthly comp. Immediate response.

Could have been the RIH dart team too.

Or, maybe the CF33 study?

Has come off a bit...
 
@MDWake Check out the recent corporate news releases for reasons why the price has spiked.
Align the dates of the news with the price bars.



Positive early signs in a drug trial will tempt both speculators and investors causing an excess demand over supply.
 
A couple of things:

1. The two threads on IMU have now been merged.
2. Some off topic posts have been removed.

Let's please get back to discussing IMU. Thanks everyone.
 
looking to open higher in further news. There's a steady flow


• FDA Fast Track Designation for Bile Duct Cancer granted for CF33-hNIS (VAXINIA) MAST Clinical Program
• FDA’s Fast Track Designation for CF33-hNIS (VAXINIA) offers closer cooperation with the FDA to expedite the MAST clinical program and subsequent potential approval process
• Fast Track provides eligibility for Accelerated Approval and Priority Review
• Imugene will utilise the Fast Track designation to work with the FDA on advancing this important drug program towards patients on an accelerated timeline
 
IMU hit a low share price a couple of months ago. This was partly due to the market not liking companies with no revenue and partly by quite a few shareholders not understanding why multiple fundraisings have occurred and not understanding the amazing product that IMU has purchased with the last fundraise.

The ducks are all lined up now and some amazing trial results are expected over this next year. Results from some recent trials and these forthcoming trials will indicate IMU as a serious contended to kill a range of cancers, including solid cancers.
 
Joe Blow said:
A couple of things:

1. The two threads on IMU have now been merged.
2. Some off topic posts have been removed.

Let's please get back to discussing IMU. Thanks everyone.
Click to expand...
Should one of these threads be removed from the selection list @Joe Blow since they have been merged ?

 
IMU is one of my selections in the 2024 CY Comp. All my selections are made from a scan and flicking through charts.

@access in the post above makes some good points about IMU which gives me more hope to go along with what I'm seeing when looking at the chart.

Has the downtrend finished yet, I hope so but I might be getting in a little early on this.
The MAs are heading in the right direction at the moment and price is above them at the moment so that's good.

 
IMU is a stock I have held for some months with pride and sold with some profit.
I do believe this has an excellent future primarily driven by some exciting news published on ASX, the topic of research, competitveness and advanced stage of progress.
The following extract is to be understood as days and months to go in 2024.
On 11 Jan the presentation would let the world know many more and wait and see

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750496-3A632641 - THIS IS A GREAT NEWS. Phase 2
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750417-3A632617 - this has the element of human benefits in terms of oncology side and $$$ for investor perspective.
market cap is only $752 M and massive cash $104M to carry forward probably Phase 3 for some of its products, for such a sleeping giant
the one year road map of progression is great. There could be some serious ups or downs in Q4 2024.




 
2024 Comp January Update:

Only very early in the year and IMU price hasn't moved much and no sellers are dumping stock at the moment so that's a good sign.

I did notice a ASX Announcement on the 10/1/2024 titled Imugene Presentation to JPMorgan Healthcare Conference.
Hopefully this might bring on some large volume on buying in the near future, once digested.

IMU:ASX Announcement - Imugene Presentation to JPMorgan Healthcare Conference - 10 Jan 2024

Read IMU's full ASX announcement titled "Imugene Presentation to JPMorgan Healthcare Conference" from 10 Jan 2024, on Market Index.
www.marketindex.com.au
 
For the benefit of those not read the presentation

 
Share price has doubled in recent months from a low price but is read to spike on one of a number of positive announcements expected over the next few months.
 
IMU, my 2024 tip. @debtfree - fulfilling the condition of one minimum posting per month
I am very positive on IMU future and surely by the end of Nov 24.
Not just wish but based on recommendations, company report and also seeing what stock specialists chart predict its performance as a strong buy




https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02768426-3A635633 DIRECTOR TRANSACTION





 

Attachments

  • 1709121663499.png
    29.1 KB · Views: 2
IMU currently have 5 possible cancer cures in development trials and all are progressing as well as expected.

One of these trials is for Vaxinia. FDA are so impressed with the trial so far that in Nov '23 they provided Fast Track approval for the trial.

The success rates for Fast Track applications submitted to the FDA's Center for Drug Evaluation and Research (CDER) range between 70% and 80%.

So IMU are in regular communication with the FDA and, as IMU are treating a type of cancer that is not treatable at present, could possibly have trials finish earlier than normal if FDA are satified with results. IMU can then use this product treatment to then cross-over to treat other types of cancer with FDA consent.

A big year coming up.
 
You must log in or register to reply here.

Similar threads

T
MXD - Matrix Gold
Replies
0
Views
5K
Trader Paul
T
T
GGX - Gas2GridLimited
2
Replies
30
Views
8K
barney
Y
MYG - Mutiny Gold
2
Replies
23
Views
11K
System
Y
POW - Protean Energy
2 3
Replies
42
Views
14K
System
Y
TEX - Target Energy
2 3
Replies
59
Views
16K
Sim81
S
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...